Results 11 to 20 of about 3,020 (217)

Tocolytic agents and the failure to improve neonatal outcomes

open access: yesPregnancy
Premature delivery has long been a major problem in obstetrics. Increased perinatal morbidity and mortality as well as substantial health care costs, both short and long term, have driven the efforts to combat this complication.
Jack FitzSimmons, Emily Oliver
doaj   +2 more sources

Synergistic effects of nifedipine and indomethacin in tocolysis: A translational study. [PDF]

open access: yesInt J Gynaecol Obstet
International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1418-1420, December 2025.
Yart L, Cohen M, Martinez de Tejada B.
europepmc   +2 more sources

School Performance After Maintenance Tocolysis With Nifedipine for Threatened Preterm Birth: 12-Year Follow-Up of the APOSTEL 2 Trial. [PDF]

open access: yesBJOG
ABSTRACT Objective To evaluate school performance at 12 years of age in children prenatally exposed to maintenance tocolysis with nifedipine versus placebo. Design 12‐year follow‐up of the multicentre APOSTEL 2 trial, in which participants with threatened preterm birth between 26+0 and 32+2 weeks of gestation, who remained pregnant after initial 48‐h ...
van der Windt LI   +8 more
europepmc   +2 more sources

Betamethasone use and risk factors for pulmonary edema during the perinatal period: a single-center retrospective cohort study in Japan

open access: yesBMC Pregnancy and Childbirth, 2022
Background A few studies have reported that maternal administration of antenatal corticosteroids increased the risk of pulmonary edema (PE). However, despite the increasing usage rate of betamethasone as antenatal corticosteroid, maternal administration ...
Takashi Nishikawa, Ken Fukuhara
doaj   +1 more source

Tocolytic Therapy Inhibiting Preterm Birth in High-Risk Populations: A Systematic Review and Meta-Analysis

open access: yesChildren, 2023
This systematic review aimed to identify the benefits and possible harms of tocolytic therapy for preterm labour management in the context of pregnant women with extremely preterm birth, multiple gestations, or growth-restricted foetuses. A comprehensive
Noyuri Yamaji   +9 more
doaj   +1 more source

Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair

open access: yesCase Reports in Anesthesiology, 2021
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immediate postoperative period is commonly treated with magnesium sulfate.
Denis Snegovskikh   +6 more
doaj   +1 more source

Nifedipine and indomethacin in preventing preterm labor under 32 gestational weeks

open access: yesGülhane Tıp Dergisi, 2022
Aims:This study compared nifedipine and indomethacin treatments, commonly used tocolytic agents, in terms of efficacy and maternal side effects.Methods:This retrospective study included pregnant women spontaneous preterm labor between 24 and 32 weeks of ...
Gülşah Dağdeviren   +5 more
doaj   +1 more source

Southeast Nigerian polyherbal (AJUMBISE): A potential uterotonic and tocolytic agents

open access: yesScientific African, 2020
Ajumbise is a polyherbal used by women in southeast Nigeria to enhance labor, expel retained placenta and blood clots after delivery, relief postpartum and menstrual pains and promote involution of the uterus.
S.N. Ijioma   +4 more
doaj   +1 more source

Maternal pulmonary edema after 46 h of ritodrine hydrochloride administration: A case report

open access: yesCase Reports in Women's Health, 2020
Introduction: Ritodrine hydrochloride is still widely used as a tocolytic agent in Japan, but it can cause maternal pulmonary edema, which may paradoxically induce preterm birth. Here we present a case of severe pulmonary edema due to
Tsuyoshi Murata   +7 more
doaj   +1 more source

Atosiban in the management of preterm labour [PDF]

open access: yes, 2011
Peer reviewedPublisher ...
Bhattacharya, Sohinee   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy